The overall number of COVID-19 cases in India has increased to 3,03,62,848, with 45,951 new infections recorded in one day and 2.94 crores recoveries, according to statistics updated on Wednesday by the Union Health Ministry. With 817 additional fatalities, the death rate rose to 3,98,454.
Meanwhile, Indian Covaxin, produced by Bharat Biotech in conjunction with the Indian Medical Research Council, efficiently suppresses coronavirus strains of both Alpha and Delta as stated by the US National Institute of Health. The NIH reports the findings of two blood serum experiments conducted by Covaxin to reveal that the vaccination produces antibodies that successfully neutralize the SARS-CoV-2 variations of B.1.1.7 (Alpha) and B.1. 617 (Delta), originally discovered in both the United Kingdom and India.
Discussion about this post